Health

Results: 5581-5592 of 6025

PR Newswire associated0

Jazz Pharmaceuticals to Report 2023 Third Quarter Financial Results on November 8, 2023

Sangamo Therapeutics Announces Third Quarter 2023 Conference Call and Webcast

PR Newswire associated0

Qilu Pharmaceutical announces the latest results from its clinical study on QL1706, in combination with chemotherapy, as a first-line treatment for recurrent or metastatic cervical cancer

First Patient Dosed for MRCT Phase 3 Study on First-Line LS-SCLC of Henlius Anti-PD-1 mAb Serplulimab in Europe

PR Newswire associated0

Cumulus Neuroscience Presents Data at CTAD 2023 Annual Meeting

LivaNova to Present at the Stifel and Wolfe Healthcare Conferences

PR Newswire associated0

FDA Meeting Feedback Puts Turn Biotechnologies on Track to be First Longevity Company Taking Cell Rejuvenation Therapy to Clinic

PR Newswire associated0

NEWLY-LAUNCHED AMAZFIT ACTIVE AND AMAZFIT ACTIVE EDGE INTRODUCE A STYLISH WAY TO STAY ACTIVE & STAY HEALTHY

PR Newswire associated0

ESAOTE's new S-scan Open redefines excellence in magnetic resonance imaging

Velocity aggressively expands MASH/MASLD capabilities with latest site acquisitions

PR Newswire associated0

Alkermes plc Reports Third Quarter 2023 Financial Results

RQM+™ Appoints Eric Pauls as Chief Customer Officer